| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/08/2006 | US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121180 Using electrochemical solution containing metal compound and bioactive materials; contacting substrate |
| 06/08/2006 | US20060121128 Increasing cytosolic calcium levels in airway epithelial cell by contacting purinergic (P2X) receptors on cell with zinc chloride; cystic fibrosis, asthma, allergies, polycystic kidney disease and salt-sensitive hypertension syndromes, diabetes; drug screening; nasal spray |
| 06/08/2006 | US20060121091 Cellular uptake of bioactive agents |
| 06/08/2006 | US20060121035 Methods for treating diabetes |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | DE102004059460A1 Solid or liquid composition, useful e.g. to promote and/or support digestive- and liver activity and prevent and/or treat digestive complaints, comprises artichoke ingredients in combination with pineapple and/or papaya ingredients |
| 06/08/2006 | CA2590720A1 Heteroaromatic glucokinase activators |
| 06/08/2006 | CA2589896A1 Indole derivatives for use as ppar active compounds |
| 06/08/2006 | CA2589800A1 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
| 06/08/2006 | CA2589797A1 Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of hiv-infected patients |
| 06/08/2006 | CA2589537A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
| 06/08/2006 | CA2589483A1 Substituted piperazines as cb1 antagonists |
| 06/08/2006 | CA2589118A1 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
| 06/08/2006 | CA2589105A1 Tetrahydropyrane derivatives for use as antidiabetics |
| 06/08/2006 | CA2588980A1 Vasopressin-binding l-nucleic acid |
| 06/08/2006 | CA2588953A1 Ppar active compounds |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2587524A1 Substituted benzoquinolizine derivates |
| 06/07/2006 | EP1666607A1 METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10 |
| 06/07/2006 | EP1666585A1 Macroencapsulated secretory cells |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666479A1 Crystal of heterocyclic compound |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666472A1 Phenylacetic acid derivative, process for producing the same, and use |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1666467A1 11Beta-HSD1 Inhibitors |
| 06/07/2006 | EP1666092A2 Drug combination comprising a fatty acid and a uridine compound. |
| 06/07/2006 | EP1666067A1 Drug containing chymase inhibitor as the active ingredient |
| 06/07/2006 | EP1666054A1 Method for administering insulinotropic peptides |
| 06/07/2006 | EP1666048A2 Method for producing insulin from a natural source and insulin |
| 06/07/2006 | EP1666034A1 Pharmaceutical combination comprising a biguanide |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664798A2 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
| 06/07/2006 | EP1664344A1 Method of diagnosis of obesity |
| 06/07/2006 | EP1664047A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 06/07/2006 | EP1664022A1 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 06/07/2006 | EP1664013A1 Calcilytic compounds |
| 06/07/2006 | EP1663990A1 Polymorphic forms of a known antihyperlipemic agent |
| 06/07/2006 | EP1663989A1 CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT |
| 06/07/2006 | EP1663980A1 Quinoline compounds and pharmaceutical compositions containing them |
| 06/07/2006 | EP1663969A1 Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
| 06/07/2006 | EP1663395A1 Multi-system therapy for diabetes, the metabolic syndrome and obesity comprising a hypoglycemic agent |
| 06/07/2006 | EP1663298A2 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 06/07/2006 | EP1663289A2 Methods for treating or ameliorating ghrelin-associated diseases and disorders |
| 06/07/2006 | EP1663266A1 Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilisation of glycemia |
| 06/07/2006 | EP1663244A2 Pteridine derivatives for the treatment of septic shock and tnf-alpha-related diseases. |
| 06/07/2006 | EP1663215A1 Novel medical use of selective cb1- receptor antagonists |
| 06/07/2006 | EP1663205A1 Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/07/2006 | EP1663200A2 Combination therapy for glycaemic control |
| 06/07/2006 | EP1663193A1 Sulfonamide derivatives for the treatment of diabetes |
| 06/07/2006 | EP1663191A1 Novel composition comprising rosiglitazone and another antidiabetic agent |
| 06/07/2006 | EP1663182A1 Rapid dissolution formulation of a calcium receptor-active compound |
| 06/07/2006 | EP1662906A1 Compositions for the treatment and prevention of diabetes mellitus |
| 06/07/2006 | EP1662876A2 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1414487B1 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 06/07/2006 | EP1411899A4 Taste masking composition |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1383523B1 Agent for treating diabetes mellitus |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1285654B1 Autonomic system controlling agents and health drinks and foods |
| 06/07/2006 | EP1265629B1 Use of growth hormone in low dose |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1124592B1 Textured and porous silicone rubber |
| 06/07/2006 | EP1104307B1 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | CN1784415A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/07/2006 | CN1784225A Angiotensin II receptor blockers for preventing the development or progression of microvascular disease due to diabetes |
| 06/07/2006 | CN1784221A Compositions for affecting weight loss |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781915A Method for producing an oxazolylethanol derivative |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1781537A Shengmai injection and its preparing method |
| 06/07/2006 | CN1781529A Liuweidihuang multiple vatimines and its preparing method |
| 06/07/2006 | CN1781528A Plant essence with equalized fat acids |
| 06/07/2006 | CN1781511A Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
| 06/07/2006 | CN1781507A American ginseng soft capsule |
| 06/07/2006 | CN1781490A Compound injection composed of borneol and erigeron breviscapus and its preparing method |
| 06/07/2006 | CN1781486A Composite amino acid and vitamine capsule preparation and its preparing method |
| 06/07/2006 | CN1781484A Compound nicotinic acid slow releasing capsule and its preparing method |
| 06/07/2006 | CN1781483A Treatment of diabetes with thiazolidinedione and metformin |
| 06/06/2006 | US7056950 Compositions of biochemical compounds involved in bioenergy metabolism of cells |
| 06/06/2006 | US7056949 Liver disorders, dietetics; weight ratio of glycerides to diglycerides |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056939 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3) |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056924 Substituted heterocyclic compounds |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments |